https://www.ncbi.nlm.nih.gov/pubmed/28212538
Abstract
Brain
ischemia causes irreversible damage to functional neurons in cases of
infarct. Promoting endogenous neurogenesis to replace necrotic neurons
is a promising therapeutic strategy for ischemia patients. The
neuroprotective role of sevoflurane preconditioning implies that it
might also enhance endogenous neurogenesis and functional restoration in
the infarct region. By using a transient middle cerebral artery
occlusion (tMCAO) model, we discovered that endogenous neurogenesis was
enhanced by sevoflurane preconditioning. This enhancement process is
characterized by the promotion of neuroblast proliferation within the
subventricular zone (SVZ), migration and differentiation into neurons,
and the presence of astrocytes and oligodendrocytes at the site of
infarct. The newborn neurons in the sevoflurane preconditioning group
showed miniature excitatory postsynaptic currents (mEPSCs), increased
synaptophysin and PSD95 staining density, indicating normal neuronal
function. Furthermore, long-term behavioral improvement was observed in
the sevoflurane preconditioning group consistent with endogenous
neurogenesis. Further histological analyses showed that sevoflurane
preconditioning accelerated microglial activation, including migration,
phagocytosis and secretion of brain-derived neurotrophic factor (BDNF).
Intraperitoneal injection of minocycline, a microglial inhibitor,
suppressed microglial activation and reversed neurogenesis. Our data
showed that sevoflurane preconditioning promoted microglial activities,
created a favorable microenvironment for endogenous neurogenesis and
accelerated functional reconstruction in the infarct region.
KEYWORDS:
ischemia and reperfusion; microglia; neurogenesis; sevoflurane preconditioning; stem cells- PMID:
- 28212538
- DOI:
- 10.18632/oncotarget.15325
No comments:
Post a Comment